glp 1 and alzheimer's study Disappointing GLP-1 Results in Trial: Underscores Promise (and Limits) of Single-Agent Approaches High-stakes Novo Nordisk Alzheimer's studies

Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems-A Pharmaceutical Perspective

Peptide therapy uses peptides to communicate and direct cells to perform the functions specific to those peptides

Please consider a discontinuation trial of oxybutynin and non-pharmacologic options for overactive bladder. Identifying Medications for Discontinuation Upon establishing goals of care, the next step is to engage the patient or caregiver and decide whether to deprescribe any medications

These data indicated that the GLA-mutant kidney organoids recapitulated human renal Fabry disease

Chronic gastroparesis can be caused by other types of damage to the vagus nerve, such as abdominal surgery

Its effects come on relatively quickly and, if administration is stopped, it clears the system rapidly